Recombinant Protochlamydia amoebophila 50S ribosomal protein L35 (RpmI) is a component of the large ribosomal subunit in Protochlamydia amoebophila . Ribosomal proteins like RpmI are essential for ribosome assembly, stability, and function in protein synthesis . Protochlamydia amoebophila is an obligate intracellular bacterium, and studying its ribosomal proteins can provide insights into its unique cellular processes and interactions with its host .
3.1. Impact of L35 Depletion
In vivo depletion of L35 leads to a deficit in 60S ribosomal subunits and the appearance of half-mer polysomes . Processing of the 27SB to 7S pre-rRNAs is significantly delayed upon L35 depletion, blocking the release of pre-60S ribosomal particles from the nucleolus to the nucleoplasm .
3.2. Effects on Cell Cycle
Flow cytometry analysis indicated that L35-depleted cells experience a mild delay in the G1 phase of the cell cycle .
3.4. L35 Interaction with rRNA
L35 might bind mature 5.8S rRNA at equivalent positions to those where archaeal L29 interacts with mature 23S rRNA within domain I .
What is Protochlamydia amoebophila 50S ribosomal protein L35 (rpmI) and why is it significant for research?
Protochlamydia amoebophila 50S ribosomal protein L35 (rpmI) is a component of the large ribosomal subunit in this amoebal endosymbiont. The significance of this protein lies in its role within the central protuberance (CP) structure of bacterial ribosomes. While not as extensively studied as other ribosomal proteins like L5, L35 is part of the protein cluster that includes L5, L16, L18, L25, L27, L31, and L33, which collectively contribute to the functionality of the 50S subunit . As a member of the Chlamydiae group, P. amoebophila represents an evolutionary intermediate between pathogenic chlamydiae and free-living bacteria, making its ribosomal components valuable for comparative studies of bacterial translation machinery.
How is recombinant P. amoebophila 50S ribosomal protein L35 typically expressed and purified?
Recombinant P. amoebophila rpmI can be expressed in multiple heterologous systems:
| Expression Host | Advantages | Considerations |
|---|---|---|
| E. coli | High yield, rapid growth, cost-effective | May form inclusion bodies requiring refolding |
| Yeast | Post-translational modifications | Longer cultivation time, more complex protocols |
| Baculovirus | Higher eukaryotic modifications | Higher cost, specialized equipment needed |
| Mammalian cells | Most complex modifications | Highest cost, lowest yield |
Purification typically involves affinity chromatography utilizing tagged constructs (His-tag being common), followed by size exclusion chromatography to achieve ≥85% purity as verified by SDS-PAGE . For functional studies, additional purification steps may be necessary to remove potential endotoxin contamination, particularly when expressed in bacterial systems.
What structural features characterize P. amoebophila 50S ribosomal protein L35?
While the specific structural details of P. amoebophila L35 are not extensively documented in the search results, ribosomal protein L35 typically:
Contains approximately 60-70 amino acids
Adopts a primarily α-helical structure
Interacts directly with rRNA in the 50S subunit
Is located near the central protuberance region
The protein's structure would be expected to contain conserved residues that mediate RNA binding and interactions with neighboring ribosomal proteins such as L27, L31, and L33, which are known to cluster together in the assembled ribosome . Comparative analysis with L35 from other bacterial species would reveal evolutionary conservation patterns reflecting functional constraints on this ribosomal component.
How does P. amoebophila L35 contribute to ribosome assembly and what methods can assess this function?
Based on studies of related ribosomal proteins, L35 likely contributes to the final stages of 50S subunit assembly. From research on E. coli ribosomes, we know that central protuberance proteins (including L35) are incorporated during later assembly phases . To assess L35's role in assembly:
Methodology:
In vitro reconstitution assays: Ribosomes can be reconstituted from purified components with or without L35, followed by functional testing
Pulse-chase experiments: Track L35 incorporation timing during ribosome biogenesis
Cryo-EM analysis: Visualize assembly intermediates with and without L35
In vivo depletion studies: Similar to L5 depletion studies , conditional expression systems can be used to deplete L35 and observe effects on ribosome assembly
L35 absence would likely affect the stability of neighboring components in the central protuberance structure, potentially creating assembly defects similar to those observed with L5 depletion, where several CP proteins (L16, L18, L25, L27, L31, L33) were also missing from resulting particles .
What techniques are optimal for assessing the purity and activity of recombinant P. amoebophila L35?
Purity Assessment:
Western blotting with anti-L35 antibodies
Mass spectrometry (particularly LC-MS/MS for identity confirmation)
Size exclusion chromatography profiles
Activity/Functionality Assessment:
Ribosome reconstitution assays (measuring incorporation into 50S subunits)
RNA binding assays (electrophoretic mobility shift assays with rRNA fragments)
Thermal shift assays to evaluate protein folding and stability
Circular dichroism to assess secondary structure integrity
The combination of these techniques provides comprehensive characterization of both purity and functional integrity of the recombinant protein, critical for ensuring experimental reproducibility in downstream applications.
How can recombinant P. amoebophila L35 be used to study host-pathogen interactions?
Protochlamydia amoebophila has been studied for its interactions with amoebae and potentially with human cells. As demonstrated in studies with other Protochlamydia components, the bacterium can induce apoptosis in human immortal HEp-2 cells . Recombinant L35 could be used to:
Investigate whether ribosomal proteins like L35 are recognized by host immune systems
Study potential moonlighting functions outside of the ribosome
Develop antibodies for tracking bacterial protein expression during infection cycles
Examine interactions with host ribosomal machinery
Experimental approach:
Production of fluorescently labeled L35 to track localization in host cells
Pull-down assays to identify host interaction partners
ELISA assays to measure antibody responses to L35 in infection models
Microarray analysis to detect host transcriptional responses to L35 exposure
These approaches could reveal whether bacterial ribosomal proteins play roles beyond protein synthesis during host-pathogen interactions .
What are the methodological considerations for studying L35 in the context of P. amoebophila metabolic activity?
P. amoebophila elementary bodies (EBs) demonstrate unexpected metabolic activity that challenges traditional views of this developmental stage . Studying L35 in this context requires specialized approaches:
Methodology:
Developmental stage-specific analysis: Isolate EBs and reticulate bodies (RBs) using density gradient ultracentrifugation
Activity monitoring: Use CTC reduction assays to correlate ribosomal activity with respiratory function
In situ protein labeling: Apply techniques like BONCAT (bio-orthogonal non-canonical amino acid tagging) to detect newly synthesized L35 during host-free periods
Isotope ratio mass spectrometry (IRMS): Measure protein synthesis activity when supplemented with labeled amino acids
Technical challenges include:
Maintaining viability of P. amoebophila during experimentation
Distinguishing bacterial proteins from host contaminants
Working with the fastidious growth requirements of this obligate intracellular organism
These approaches can connect L35 synthesis and incorporation to the surprising metabolic capabilities of P. amoebophila EBs, potentially revealing specialized translational regulation during different developmental stages .
How can molecular genetic techniques be applied to study L35 function in P. amoebophila despite its obligate intracellular lifestyle?
Studying gene function in obligate intracellular bacteria presents significant challenges. For P. amoebophila L35 research, several sophisticated approaches can overcome these limitations:
| Technique | Application to L35 Research | Limitations |
|---|---|---|
| RNA interference in host cells | Disrupt host factors required for L35 function | Indirect approach, may affect multiple pathways |
| Antisense RNA expression | Targeted inhibition of rpmI expression | Requires efficient delivery system |
| Host-free systems | Study L35 function during extracellular phase | Limited timeframe of bacterial viability |
| Heterologous expression systems | Express L35 variants in E. coli to assess function | May not replicate natural environment |
| Fluorescence in situ hybridization (FISH) | Localize L35 mRNA during developmental cycle | Requires optimization for intracellular detection |
A particularly promising approach involves adapting techniques from transposon-insertion sequencing studies developed for other pathogens , potentially allowing identification of genes that interact functionally with rpmI despite the challenges of working with an intracellular organism.
What is the relationship between L35 and other central protuberance proteins in the context of ribosomal evolution?
Advanced evolutionary analysis of L35 can provide insights into ribosomal evolution across bacterial phyla:
Research approaches:
Comparative genomics: Analyze L35 sequence conservation across Chlamydiae and related bacteria
Structural bioinformatics: Model co-evolution networks between L35 and other CP proteins
Ancestral sequence reconstruction: Infer evolutionary trajectories of L35 within bacterial lineages
The interdependence between L35 and other CP components (L5, L16, L18, L25, L27, L31, L33) observed in E. coli studies suggests a coordinated evolutionary module. Analysis of L5-depleted ribosomes revealed that L35 absence correlates with missing CP structure, indicating these proteins evolved as a functional unit .
This evolutionary perspective on L35 can potentially illuminate how P. amoebophila, positioned between environmental bacteria and obligate pathogens, represents an intermediate evolutionary stage in the transition to obligate intracellular lifestyle.
How might recombinant P. amoebophila L35 be engineered for specialized research applications?
Advanced protein engineering approaches can enhance the utility of recombinant L35:
Engineering strategies:
Site-directed mutagenesis: Create L35 variants to map functional domains
Fusion constructs: Generate L35 fusions with fluorescent proteins or affinity tags for specialized applications
Protein complementation assays: Design split-reporter systems to study L35 interactions
Thermostability engineering: Modify L35 for enhanced stability during experimental manipulation
Applications in experimental systems:
| Engineering Approach | Research Application | Expected Outcome |
|---|---|---|
| Cysteine incorporation | Site-specific labeling for FRET studies | Dynamic information on L35 interactions during assembly |
| Chimeric L35 constructs | Domain swapping with other bacterial L35 proteins | Functional conservation mapping |
| Conditionally stable L35 | Temperature-sensitive variants | Temporal control of L35 function |
| Biotinylated L35 | Pull-down experiments | Identification of novel interaction partners |
These engineered variants could overcome limitations in studying this protein from an obligate intracellular bacterium while providing molecular tools for broader ribosomal research applications.
What role might P. amoebophila L35 play in the developmental cycle of this organism in amoebal hosts?
P. amoebophila undergoes a biphasic developmental cycle similar to other Chlamydiae, transitioning between elementary bodies (EBs) and reticulate bodies (RBs). Recent studies have shown that EBs maintain unexpected metabolic activity .
Research considerations:
During the transition from EB to RB (the metabolically active form), ribosome activation is critical
L35 synthesis and incorporation likely occurs during early stages of RB development
Respiratory activity detected in EBs suggests potential translational activity involving L35-containing ribosomes
Studies using CTC reduction assays have shown that respiratory activity in EB fractions cannot be solely attributed to contamination with other developmental stages
Methodological approach:
Stage-specific proteomics to quantify L35 abundance across the developmental cycle
Ribosomal profiling during EB-to-RB transition
Fluorescence microscopy with L35-specific antibodies to track ribosome distribution
Host-free incubation studies to evaluate translation in isolated developmental forms
These approaches could reveal how L35-containing ribosomes contribute to the surprising metabolic capabilities observed in P. amoebophila developmental forms .